Journals / Uludağ Üniversitesi Tıp Fakültesi Dergisi / 2026 / Cilt: 52

Perception-Driven Determinants of Pandemic-Related Anxiety in Familial Mediterranean Fever and Behçet’s Disease

Ailesel Akdeniz Ateşi ve Behçet Hastalığında Pandemiye Bağlı Anksiyetenin Algı Temelli Belirleyicileri

Altuğ Güner(Department of Rheumatology, Bursa City Hospital, Bursa, Türkiye.)0000-0001-7220-0288
Hüseyin Ediz Dalkılıç(Division of Rheumatology, Department of Internal Medicine, Bursa Uludağ University Faculty of Medicine, Bursa, Türkiye.)0000-0001-8645-2670
Yavuz Pehlivan(Division of Rheumatology, Department of Internal Medicine, Bursa Uludağ University Faculty of Medicine, Bursa, Türkiye.)0000-0002-7054-5351
Pages
—
Publication Date
2026-09-18
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These findings highlight the potential importance of psychosocial assessment and risk communication strategies during infectious outbreaks.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Infectious outbreaks impose substantial psychological burden beyond their biomedical impact.
📊
Key Findings & Data:In this cross-sectional study, 61 patients (FMF n=30; BD n=31) were consecutively recruited from a tertiary rheumatology clinic.
💡
Conclusion & Impact:These findings highlight the potential importance of psychosocial assessment and risk communication strategies during infectious outbreaks.
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Ailesel Akdeniz Ateşi · Behçet Hastalığı · COVID-19

Abstract

Infectious outbreaks impose substantial psychological burden beyond their biomedical impact. Patients with chronic inflammatory diseases may be particularly vulnerable due to perceived infection risk and treatment-related concerns. This study aimed to compare coronavirus-related anxiety levels in patients with Familial Mediterranean Fever (FMF) and Behçet’s disease (BD) and to identify independent determinants of anxiety. In this cross-sectional study, 61 patients (FMF n=30; BD n=31) were consecutively recruited from a tertiary rheumatology clinic. Anxiety was assessed using the validated Turkish version of the Coronavirus Anxiety Scale (CAS). Demographic, clinical, and contextual variables were recorded. Group comparisons were performed using appropriate parametric and non-parametric tests. Multivariable linear regression was used to examine factors independently associated with anxiety. FMF patients had higher CAS scores than BD patients (2.97±3.05 vs 1.60±2.91; p=0.019; Cohen’s d=0.46). In multivariable analysis, female sex (B=1.80; 95% CI 0.14–3.46; p=0.034) and environmental COVID-19 exposure (defined as the presence of a confirmed case in the close surroundings) (B=2.71; 95% CI 0.89–4.54; p=0.004) were independently associated with higher anxiety scores. Neither exploratory analyses nor multivariable modeling demonstrated significant associations between anxiety scores and FMF diagnosis, age, disease duration, self-rated COVID-19 illness severity, comorbidity status, biologic therapy, or corticosteroid exposure. The model explained 26.1% of the variance in anxiety scores (R²=0.261). Pandemic-related anxiety in patients with FMF and BD appeared to be more closely associated with environmental COVID-19 exposure and female sex than with the disease-related variables evaluated in this study. These findings highlight the potential importance of psychosocial assessment and risk communication strategies during infectious outbreaks.

Özet

Enfeksiyöz salgınlar, biyomedikal etkilerinin ötesinde önemli bir psikolojik yük oluşturmaktadır. Kronik inflamatuvar hastalığı olan bireyler, algılanan enfeksiyon riski ve tedaviye bağlı kaygılar nedeniyle özellikle hassas olabilir. Bu çalışmada, Ailesel Akdeniz Ateşi (FMF) ve Behçet hastalığı (BH) olan hastalarda COVID-19 ile ilişkili anksiyete düzeylerinin karşılaştırılması ve anksiyetenin bağımsız belirleyicilerinin ortaya konulması amaçlandı. Bu kesitsel çalışmada, üçüncü basamak bir romatoloji kliniğinden ardışık olarak dahil edilen toplam 61 hasta (FMF n=30; BH n=31) değerlendirildi. Anksiyete, Koronavirüs Anksiyete Ölçeği’nin (CAS) valide edilmiş Türkçe versiyonu ile ölçüldü. Demografik, klinik ve bağlamsal değişkenler kaydedildi. Gruplar arası karşılaştırmalar uygun parametrik ve non-parametrik testlerle yapıldı. Anksiyete ile bağımsız ilişkili faktörleri belirlemek amacıyla çok değişkenli lineer regresyon analizi uygulandı. FMF hastalarında CAS skorları BH hastalarına kıyasla daha yüksekti (2,97±3,05’e karşı 1,60±2,91; p=0,019; Cohen’s d=0,46). Çok değişkenli analizde kadın cinsiyet (B=1,80; %95 GA 0,14–3,46; p=0,034) ve çevresel COVID-19 maruziyeti (yakın çevrede doğrulanmış vaka varlığı) (B=2,71; %95 GA 0,89–4,54; p=0,004) daha yüksek anksiyete skorları ile bağımsız olarak ilişkili bulundu. FMF tanısı, yaş, hastalık süresi, öz-bildirime dayalı COVID-19 hastalık şiddeti, komorbidite varlığı, biyolojik tedavi ve kortikosteroid kullanımı ile anksiyete skorları arasında anlamlı ilişki saptanmadı. Model, anksiyete skorlarındaki varyansın %26,1’ini açıkladı (R²=0,261). FMF ve BH hastalarında pandemi ile ilişkili anksiyete, hastalığa özgü değişkenlerden ziyade çevresel maruziyet ve kadın cinsiyet ile daha yakından ilişkili görünmektedir. Bu bulgular, enfeksiyöz salgınlar sırasında psikososyal değerlendirme ve risk iletişimi stratejilerinin önemine işaret etmektedir.

🔖

Cite This Article

Güner, A., Dalkılıç, H. E., Pehlivan, Y., *, A. G. (2026). Perception-Driven Determinants of Pandemic-Related Anxiety in Familial Mediterranean Fever and Behçet’s Disease. Uludağ Üniversitesi Tıp Fakültesi Dergisi, Cilt: 52. https://doi.org/10.32708/uutfd.1942544

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Vindegaard N, Benros ME. COVID-19 pandemic and mental health consequences: systematic review of the current evidence. Brain Behav Immun. 2020;89:531-542. doi:10.1016/j.bbi.2020.05.048.
  2. Gianfrancesco M, Hyrich KL, Al-Adely S, et al. Characteristicsassociated with hospitalisation for COVID-19 in people withrheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry. AnnRheum Dis. 2020;79(7):859-866. doi:10.1136/annrheumdis-2020-217871.
  3. Matcham F, Rayner L, Steer S, Hotopf M. The prevalence ofdepression in rheumatoid arthritis: a systematic review andmeta-analysis. Rheumatology (Oxford). 2013;52(12):2136-2148. doi:10.1093/rheumatology/ket169.
  4. Marrie RA, Walld R, Bolton JM, et al. Psychiatric comorbidityincreases mortality in immune-mediated inflammatory diseases.Lancet Psychiatry. 2017;4(6):459-468. doi:10.1016/S2215-0366(17)30098-2.
  5. Dantzer R, O'Connor JC, Freund GG, Johnson RW, Kelley KW. From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 2008;9(1):46-56. doi:10.1038/nrn2297.
  6. Ozen S, Batu ED, Demir S. Familial Mediterranean fever:recent developments in pathogenesis and new recommendations for management. Front Immunol. 2017;8:253. doi:10.3389/fimmu.2017.00253.
  7. Yazici H, Seyahi E, Hatemi G, Yazici Y. Behcet syndrome: a contemporary view. Nat Rev Rheumatol. 2018;14(2):107-119. doi:10.1038/nrrheum.2017.208.
  8. Hao F, Tan W, Jiang L, et al. Do psychiatric patients experience more psychiatric symptoms during COVID-19pandemic and lockdown? Brain Behav Immun. 2020;87:100-106. doi:10.1016/j.bbi.2020.05.026.
  9. Sacchi MC, Tamiazzo S, Stobbione P, et al. Psychologicalimpact of COVID-19 in patients with autoimmune diseases. JAutoimmun. 2021;121:102669. doi:10.1016/j.jaut.2021.102669.
  10. Picchianti Diamanti A, Cattaruzza MS, Di Rosa R, et al.Psychological distress in patients with autoimmune arthritisduring the COVID-19 induced lockdown in Italy.Microorganisms. 2020;8(11):1818. doi:10.3390/ microorganisms8111818.
  11. von Elm E, Altman DG, Egger M, et al. The STROBEstatement: guidelines for reporting observational studies. PLoSMed. 2007;4(10):e296. doi:10.1371/journal.pmed.0040296.
  12. Livneh A, Langevitz P, Zemer D, et al. Criteria for thediagnosis of familial Mediterranean fever. Arthritis Rheum.1997;40(10):1879-1885. doi:10.1002/art.1780401023.
  13. International Study Group for Behcet's Disease. Criteria fordiagnosis of Behcet's disease. Lancet. 1990;335(8697):1078-1080. doi:10.1016/0140-6736(90)92643-V.
  14. Lee SA. Coronavirus Anxiety Scale: a brief mental health screener for COVID-19 related anxiety. Death Stud. 2020;44(7):393-401. doi:10.1080/07481187.2020.1748481.
  15. Bicer I, Cakmak C, Demir H, Kurt ME. Coronavirus Anxiety Scale short form: Turkish validity and reliability study. ArchNeuropsychiatry. 2020;57(4):296-302. doi:10.29399/npa.28049
  16. Beck AT, Clark DA. An information processing model ofanxiety: automatic and strategic processes. Behav Res Ther.1997;35(1):49-58. doi:10.1016/S0005-7967(96)00069-1.